EPI-Q assists life sciences firms demonstrate the value of medical technology and enhance the quality of clinical practice in order to improve patient care. We help biopharmaceutical firms generate evidence to support product commercialization. EPI-Q is unique because our experts have been on the front line as healthcare decision-makers – treating patients, implementing practice guidelines, measuring quality improvement, and securing access to evidence-based medicine. Let us show you how our team can help you exceed your customers' highest expectations and achieve your most ambitious goals.
Dr. Carla Frye presents "An Analysis of the Impact of Variations in Bleeding Definitions on Study Results in Patients Receiving Antithrombotic Agents" at CADTH Symposium, April 5-7, Ottowa, ON

More news...
Enter your email address to get our latest
news and events info as soon as it is announced.